BDBM450978 1-Chloro-8-(2,4-dimethylpyrimidin-5-yl)-N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)imidazo[1,5-c]pyrimidin-5-amine::US10676479, Example 10
SMILES: Cc1ncccc1-c1cnc(NCc2c3CCOc3ccc2F)n2cnc(c12)S(C)(=O)=O
InChI Key: InChIKey=UNASHSXBPRWRBJ-UHFFFAOYSA-N
Data: 4 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human)) | BDBM450978![]() (1-Chloro-8-(2,4-dimethylpyrimidin-5-yl)-N-((5-fluo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description To assess the compounds' potency in the EED-H3K27Me3 competition binding assay, compounds were serially diluted 3-fold in DMSO to obtain a total ... | US Patent US10676479 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polycomb protein EED (Homo sapiens (Human)) | BDBM450978![]() (1-Chloro-8-(2,4-dimethylpyrimidin-5-yl)-N-((5-fluo...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | PubMed | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Michigan Curated by ChEMBL | Assay Description Inhibition of EED ( 1 to 441 residues) (unknown origin) pre-incubated for 15 mins before biotin-H3K27me3 (19 to 33 residues) addition and further inc... | J Med Chem 63: 7252-7267 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human)) | BDBM450978![]() (1-Chloro-8-(2,4-dimethylpyrimidin-5-yl)-N-((5-fluo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat... | US Patent US10676479 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human)) | BDBM450978![]() (1-Chloro-8-(2,4-dimethylpyrimidin-5-yl)-N-((5-fluo...) | PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat... | US Patent US10676479 (2020) | |||||||||||
More data for this Ligand-Target Pair |